Throughout this overview, the use of various preclinical obese, insulin- and leptin-resistant preclinical diabetic rodent models will be utilized in order to provide a better understanding of how the multiple risk factor and variables of the MetS result in cellular and organ ultrastructural remodeling and functional abnormalities. The gene discussed is INS; the disease is metabolic syndrome.